Literature DB >> 15908090

Pharmacotherapy for major depression in children and adolescents.

Karen Dineen Wagner1.   

Abstract

Major depression is a serious illness in children which adversely effects their social, academic, and emotional development. It is essential to identify safe and effective medication for the treatment of this disorder in youths. Only some selective serotonin reuptake inhibitors (citalopram, fluoxetine, sertraline) have demonstrated superiority to placebo on primary outcome measures in acute controlled treatment trials. This article will review acute efficacy studies as well as long-term studies of antidepressants for the treatment of childhood depression. Treatment recommendations are discussed and the issue of suicidality and antidepressants are addressed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15908090     DOI: 10.1016/j.pnpbp.2005.03.005

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  15 in total

Review 1.  Risk of adverse behavioral effects with pediatric use of antidepressants.

Authors:  Wayne K Goodman; Tanya K Murphy; Eric A Storch
Journal:  Psychopharmacology (Berl)       Date:  2006-12-19       Impact factor: 4.530

Review 2.  The complex role of sleep in adolescent depression.

Authors:  Greg Clarke; Allison G Harvey
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2012-04

Review 3.  Efficacy and tolerability of pharmacotherapies to aid smoking cessation in adolescents.

Authors:  Steffani R Bailey; Erin E Crew; Emily C Riske; Seth Ammerman; Thomas N Robinson; Joel D Killen
Journal:  Paediatr Drugs       Date:  2012-04-01       Impact factor: 3.022

4.  A novel early intervention for preschool depression: findings from a pilot randomized controlled trial.

Authors:  Joan Luby; Shannon Lenze; Rebecca Tillman
Journal:  J Child Psychol Psychiatry       Date:  2011-10-31       Impact factor: 8.982

5.  Depression Change Profiles in Adolescents Treated for Comorbid Depression/Substance Abuse and Profile Membership Predictors.

Authors:  Paul Rohde; Charles W Turner; Holly B Waldron; Janet L Brody; Jenel Jorgensen
Journal:  J Clin Child Adolesc Psychol       Date:  2016-02-18

6.  A Randomized, Double-Blind, Placebo-Controlled Trial of Low-Dose Sertraline in Young Children With Fragile X Syndrome.

Authors:  Laura Greiss Hess; Sarah E Fitzpatrick; Danh V Nguyen; Yanjun Chen; Kimberly N Gaul; Andrea Schneider; Kerrie Lemons Chitwood; Marwa Abd Al Azaim Eldeeb; Jonathan Polussa; David Hessl; Susan Rivera; Randi J Hagerman
Journal:  J Dev Behav Pediatr       Date:  2016-10       Impact factor: 2.225

7.  Preschool depression: homotypic continuity and course over 24 months.

Authors:  Joan L Luby; Xuemei Si; Andy C Belden; Mini Tandon; Ed Spitznagel
Journal:  Arch Gen Psychiatry       Date:  2009-08

8.  Adolescent depression: an update and guide to clinical decision making.

Authors:  Mary N Cook; John Peterson; Christopher Sheldon
Journal:  Psychiatry (Edgmont)       Date:  2009-09

9.  Early childhood depression.

Authors:  Joan L Luby
Journal:  Am J Psychiatry       Date:  2009-09       Impact factor: 18.112

Review 10.  Newer generation antidepressants for depressive disorders in children and adolescents.

Authors:  Sarah E Hetrick; Joanne E McKenzie; Georgina R Cox; Magenta B Simmons; Sally N Merry
Journal:  Cochrane Database Syst Rev       Date:  2012-11-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.